I. Lammert

Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German

P. Wust, V. Budach, K. Wernecke, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accelerated hyperfractionated radiation therapy to 70.6 Gy plus 5-FU/MMC (C-HART) is more effective than HART to 77.6 Gy alone for locally advanced head and neck cancer. Four-year results of the German ARO 95-6 trial in 384 patients

P. Wust, V. Budach, K. Wernecke, 2003 .